Ref ID: 19392
Author:
M. Hoenigl, C. Koidl, W. Duettmann, B. Huber-Krassnitzer,
B. Waitzl, P. Neumeister, V. Posch, K. Seeber, J. Wagner, H. Sill,
A. W€olfler and R. Krause
Author address:
Medical University of Graz, Austria
Full conference title:
6th Trends in Medical Mycology 2013
Date: 11 October 2014
Abstract:
Background Serum galactomannan (GM) has been established as
an important method for diagnosing invasive aspergillosis (IA). In
this study we evaluated performance of GM test in urine specimens
and compared results with those obtained in serum.
Methods The study was performed from July 2012-March 2013 in
adult patients with underlying hematological malignancies hospital-
ized at the Department of Haematology at the Medical University of
Graz in Austria and was approved by the local ethics committee.
Serum and urine samples were collected and tested twice weekly
(always on the same day). For serum samples an optical density
index (ODI) 0.5 was considered positive.
Results Each 242 serum and urine samples were collected in 75
patients (33 of those had undergone recent allogeneic stem cell trans-
plantation). 21/242 (8,7%) serum samples from 13 patients resulted
GM positive. Sensitivity, specificity, PPV and NPV for different cut-offs
for urine samples (compared to serum results) were as follows: 0.15
ODI: 33,3%, 90,5%, 25%, 93,5%; 0.1 ODI: 47,6%, 86%, 24,4%,
94,5%. A cutoff of 0.1 ODI was chosen for urine samples. 11/21 posi-
tive serum GM samples gave negative results in urine; 4 of those were
derived from a patient with increasing positive serum GM levels in
whom urine samples became positive with a 2 week delay. In 2 proba-
ble IA cases initially positive urine samples became negative under
appropriate antifungal therapy while decreasing serum samples
remained positive. 3 serum samples were considered false positives, 2
urine sample false negatives. Urine resulted positive in 31/221 nega-
tive serum GM samples. 26 of those were considered false positives.
Spearman-Rho correlation analysis revealed a significant positive cor-
relation between serum and urine samples (p < 0.001; q = 0.252).
Conclusions A significant positive correlation was found between
urine and serum GM results. Further studies are needed to evaluate
the potential role of urine GM testing in IA diagnosis
Abstract Number: p076
Conference Year: 2013
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a